Vitality Watch

Dossier pubmed review 24-sep-2025
Narrative review or expert overview without new data

The role and potential therapeutic intervention of cellular senescence in intervertebral disc degeneration.

Key claim: Cellular senescence is a central driver of intervertebral disc degeneration, and therapies that inhibit senescence may alleviate IDD pathogenesis.

Abstract

Intervertebral disc degeneration (IDD) is a common cause of low back pain that causes significant debilitation. The intricate mechanisms governing intervertebral disc homeostasis are substantially impacted by cellular senescence, which plays crucial roles in both pathological and physiological contexts. In this review, we provide a comprehensive overview of cellular senescence in the pathogenesis of IDD. Specifically, we summarize the merits and limitations of the methodologies utilized in prior investigations to determine cellular senescence and the potential regulatory mechanisms underlying it in the progression of IDD. Furthermore, we describe therapeutic strategies that aim to inhibit cellular senescence, which may alleviate the pathogenesis of IDD. At last, we discuss the challenges and prospects of translational research on targeting cellular senescence in IDD treatment.

Why this matters

Cellular senescence is a central driver of intervertebral disc degeneration, and therapies that inhibit senescence may alleviate IDD pathogenesis.

Source

Link

Briefing card

The role and potential therapeutic intervention of cellular senescence in intervertebral disc degeneration.
Stage: review · pubmed · 24-sep-2025

Cellular senescence is a central driver of intervertebral disc degeneration, and therapies that inhibit senescence may alleviate IDD pathogenesis.

Cross-references (0)

None recorded — doctrine links and citations appear here as scans and citation sweeps find them.

External: doi:10.1016/j.gendis.2025.101871

build build 880 · 2bcef25 · 2026-11-18